The Eμ-myc transgenic mouse expresses elevated levels of c-Myc in the B cell lineage and develops B cell lymphomas with associated mutations in p53 or other genes linked to apoptosis. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.